Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_assertion type Assertion NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_head.
- NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_assertion description "[The resulting tumor-selective radionuclide accumulation was high enough for a therapeutic effect of (131)I and (188)Re opening the exciting prospect of NIS-mediated radionuclide therapy of metastatic cancer using genetically engineered MSCs as gene delivery vehicles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_provenance.
- NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_assertion evidence source_evidence_literature NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_provenance.
- NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_assertion SIO_000772 23402366 NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_provenance.
- NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_assertion wasDerivedFrom befree-20140225 NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_provenance.
- NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_assertion wasGeneratedBy ECO_0000203 NP715312.RALbyB2y8yh7UPenopEkSYe3Z2MraE1UZHOmKLmMI7054130_provenance.